Ainsworth Institute Joins New Clinical Trial on Complex Regional Pain Syndrome (CRPS)

The Ainsworth Institute is proud to announce is has joined the CREATE-1 Study: CRPS Treatment Evaluation 1 Study – sponsored by Axsome Therapeutics, Inc.  This is an FDA approved trial studying the effects of a new groundbreaking oral medication to treat CRPS.  Enrollment will start shortly.

• Author
• Recent Posts

Ainsworth ASC

Latest posts by Ainsworth ASC (see all)

• Hydrodissection – Science or Science Fiction - March 23, 2021
• Facebook Live 2 – Full Video - April 2, 2020
• (Full Presentation) Top 5 Things Pain Patients Need To Know During The Coronavirus Pandemic - March 30, 2020